Nature Immunology

Nature Immunology
Title	Nature Immunology
Discipline	Immunology
Abbreviation	Nat. Immunol.
Publisher	Nature Publishing Group
History	2000–present
Frequency	Monthly

Nature Immunology Nature Immunology is a monthly peer-reviewed scientific journal covering immunology and related biomedical research. The journal is published by Nature Publishing Group and functions within the broader family of Nature titles, interacting with institutions such as the National Institutes of Health, the European Research Council, and the Howard Hughes Medical Institute. It attracts submissions from researchers at organizations including Harvard University, Stanford University, Max Planck Society, and University of Oxford.

Overview

Nature Immunology publishes original research, reviews, perspectives, and commentaries across experimental and clinical arenas, serving investigators in laboratories at Cold Spring Harbor Laboratory, Salk Institute, Dana-Farber Cancer Institute, and Institut Pasteur. The journal’s readership includes faculty at Massachusetts Institute of Technology, clinicians at Mayo Clinic, and scientists at biotechnology firms such as Genentech, Amgen, and Regeneron Pharmaceuticals. It interfaces with funding bodies like the Wellcome Trust and the Bill & Melinda Gates Foundation, and reports advances relevant to public-health agencies including the Centers for Disease Control and Prevention and the World Health Organization.

History and Development

Launched in 2000 by Macmillan Publishers as part of an expansion of the Nature Research portfolio, the journal emerged during a period of rapid growth in immunology driven by discoveries at Laboratory of Immunology, NIAID and programs at universities including University of California, San Francisco and Johns Hopkins University. Early editorial leadership drew on scholars affiliated with Scripps Research, Imperial College London, and University of Cambridge, and editorial policy evolved in dialogue with advisory boards from European Molecular Biology Laboratory and the Leibniz Association. Over time it adjusted to technological shifts exemplified by methods developed at Broad Institute and by consortia such as the Human Genome Project and the Human Cell Atlas.

Scope and Content

The journal covers cellular immunology work from groups at University of Tokyo, Peking University, and Seoul National University, translational studies from Cleveland Clinic and Karolinska Institutet, and theoretical or computational immunology associated with researchers at ETH Zurich and Princeton University. Article types encompass reports of discoveries related to innate immunity (work linked to laboratories at Scripps Research Institute), adaptive immunity studies from teams at Weizmann Institute of Science and Cold Spring Harbor Laboratory, and clinical immunotherapy reports tied to trials at Memorial Sloan Kettering Cancer Center and Vanderbilt University Medical Center. Reviews often synthesize findings from research funded by organizations such as the National Science Foundation, the European Commission, and the Medical Research Council (United Kingdom).

Editorial and Publication Details

Editorial decisions are managed by professional editors with scholarly connections to institutions like Yale University and University College London and informed by external referees based at University of Chicago, University of Pennsylvania, and Columbia University. The publication follows standard peer-review procedures employed across publishers including Elsevier and Wiley-Blackwell, and it adheres to data and ethical policies influenced by guidance from bodies such as the Committee on Publication Ethics and the International Committee of Medical Journal Editors. Production and dissemination involve partnerships with indexing services like PubMed and Web of Science and distribution channels reaching libraries at New York Public Library and university consortia associated with ARL (Association of Research Libraries).

Impact and Reception

The journal is cited alongside flagship venues such as Cell, Science, The Lancet, and Proceedings of the National Academy of Sciences in bibliometric analyses performed by Clarivate Analytics and Scopus. Its influence is measured in part through articles that inform policy at the Food and Drug Administration and contribute to guidelines by professional societies like the American Association of Immunologists and the European Academy of Allergy and Clinical Immunology. Academic reception includes awards won by authors affiliated with Nobel Prize laureate institutions, recognition at conferences such as the American Association for Cancer Research annual meeting and the International Congress of Immunology, and citation in textbooks produced by publishers like Oxford University Press and Cambridge University Press.

Notable Articles and Contributions

Noteworthy contributions published in the journal have been produced by research groups from Rockefeller University, Mount Sinai Health System, and Columbia University Irving Medical Center, and have influenced fields including cancer immunotherapy work tied to Carnegie Institution for Science, vaccine development connected to Pasteur Institute collaborations, and basic immunology studies originating from University of California, San Diego. Articles have intersected with landmark projects such as the Cancer Genome Atlas and collaborative networks including the European Molecular Biology Organization, and have been cited in reviews authored by investigators affiliated with Scripps Research and Johns Hopkins University School of Medicine.

Category:Academic journals